2018
DOI: 10.1016/j.neurobiolaging.2018.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Genetic analysis of ANXA11 variants in a Han Chinese cohort with amyotrophic lateral sclerosis in Taiwan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 0 publications
1
11
0
Order By: Relevance
“…Mutations in ANXA11 cause ALS and a related neurodegenerative disorder, frontotemporal dementia (FTD). Numerous mutations in ANXA11 have now been described by several different groups, and may account for up to 6% of familial ALS in Chinese populations (Smith et al, 2017;Tsai et al, 2018;Zhang et al, 2018a). Pathogenic mutations occur in both the N-terminal low complexity region and the C-terminal membrane binding region.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Mutations in ANXA11 cause ALS and a related neurodegenerative disorder, frontotemporal dementia (FTD). Numerous mutations in ANXA11 have now been described by several different groups, and may account for up to 6% of familial ALS in Chinese populations (Smith et al, 2017;Tsai et al, 2018;Zhang et al, 2018a). Pathogenic mutations occur in both the N-terminal low complexity region and the C-terminal membrane binding region.…”
Section: Discussionmentioning
confidence: 99%
“…Of these, annexin A11 (ANXA11) was the highest-ranked lysosome-interacting protein based on LAMP1-APEX2 proteomics. Mutations in ANXA11 are associated with ALS, a neurodegenerative disease in which dysfunction of lysosomal and RNA granule biology play causal roles (Smith et al, 2017;Tsai et al, 2018;Zhang et al, 2018a). We performed structural modeling of ANXA11 as a first step in its characterization ( Figure 2G).…”
Section: (Legend Continued On Next Page)mentioning
confidence: 99%
“…Mutations in ANXA11 were recently identified in patients with familial and sporadic ALS by whole-exome sequencing (13)(14)(15)(16). ANXA11 is a member of the Ca 2+ -dependent phospholipid-binding protein family, which comprises an extended N-terminal domain containing a binding site for another Ca 2+ -binding protein (CBP), calcyclin, and C-terminal repeated annexin (ANX) homology domains p.D40G; 0, 0.00005629, and 0.00007705 for p.G38R; 0, 0.0003659, and 0 for p.G137R; 0, 0.0003267, and 0.00000775 for p.R456H in East Asian, South Asian, and European populations, respectively).…”
Section: Introductionmentioning
confidence: 99%
“…Mutations in ANXA11 are associated with ALS, a neurodegenerative disease in which dysfunction of lysosomal and RNA granule biology play causal roles (Smith et al, 2017;Tsai et al, 2018;Zhang et al, 2018a). We performed structural modeling of ANXA11 as a first step in its characterization (Figure 2G).…”
Section: Identification Of Anxa11 As a Mediator Of Rna Granule-lysosome Associationsmentioning
confidence: 99%